Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

GEN Publishes 2015 ‘Top 10 Biopharma Clusters’ Ranking; New York-New Jersey No. 3

New Rochelle, NY, March 25, 2015 Genetic Engineering & Biotechnology News (GEN) has published its Top 10 US Biopharma Clusters List for 2015.

The new rankings include the same 10 regions as last year’s GEN List, but the top seven occupy slightly different positions.

According to GEN, the top ten biopharma clusters today are:

  1. Boston/Cambridge
  2. San Francisco/Bay Area
  3. New York/New Jersey
  4. San Diego
  5. Maryland/DC Metro
  6. Greater Philadelphia
  7. Seattle
  8. Raleigh-Durham (includes the Research Triangle Park, NC)
  9. Los Angeles
  10. Chicagoland

The New York cluster has been expanded and renamed the New York/New Jersey cluster (ranked No. 3), to better reflect the fact that the region’s biopharma resources straddle the state line — a fact long acknowledged by laboratory space real estate brokerages and even many companies, which have in recent years moved across the border, based on incentives and other factors.

To read the complete GEN story, click here.